Dexcom (DXCM) financials

Health Care Equipment · NASDAQ · Health Care

$82.29 +2.95% Close Oct 30, 2026 Live

Dexcom revenue and earnings by year

Dexcom's revenue was $4.66 billion in the fiscal year to December 31, 2025, up 15.6% from the year before. Net income was $836 million, 17.9% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 26.2% a year on average.

RevenueNet income
$0$2.00B$4.00B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue4.664.033.622.912.451.931.481.030.720.57
Revenue growth15.6%11.3%24.5%18.8%27.1%30.5%43.1%43.6%25.3%—
Gross profit2.802.442.291.881.681.280.930.660.490.38
Gross margin60.1%60.5%63.2%64.7%68.6%66.4%63.1%64.4%68.5%66.0%
Operating income0.910.600.600.390.270.300.14-0.19-0.04-0.06
Operating margin19.6%14.9%16.5%13.4%10.9%15.5%9.6%-18.1%-5.9%-11.1%
Net income0.840.580.540.340.220.550.10-0.13-0.05-0.07
Net margin17.9%14.3%14.9%11.7%8.9%28.5%6.8%-12.3%-7.0%-11.4%
Diluted EPS$2.09$1.42$1.30$0.82$0.53$1.33$0.27-$0.36-$0.15-$0.19
Free cash flow1.080.630.510.300.050.280.130.060.030.00

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open DXCM in Markets.

See also: DXCM valuation and P/E history · DXCM returns

No forecast, no recommendation. This page describes Dexcom from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.